Vland Biotech (603739.SH) obtained a new veterinary drug registration certificate.

Zhito Finance APP News: Lanhai Bio (603739.SH) announced that, upon review by the Ministry of Agriculture and Rural Affairs, the "Swine Streptococcus suis, Glaesserella parasuis, and Porcine Circovirus Type 2 Triple Inactivated Vaccine (Type 2 QH Strain + Type 5 LZ Strain + Cap Protein)" jointly applied for by the company's wholly-owned subsidiary Qingdao Lanhai Animal Health Group Co., Ltd. and other units has been approved as a Class III new veterinary drug; the "Qingying Granules" jointly applied for by the company and other units has been approved as a Class IV new veterinary drug, and the "New Veterinary Drug Registration Certificate" was issued in recent days.